Wallis–Zieff–Goldblatt syndrome
Wallis–Zieff–Goldblatt syndrome is a rare condition characterized by inherited skeletal disorders manifested mainly as rhizomelic short stature and lateral clavicular defects.<ref name=wzg88>,
Newly recognized autosomal dominant syndrome of rhizomelic shortness with clavicular defect, Am J Med Genet, 1988, Vol. 31(Issue: 4), pp. 881–5, DOI: 10.1002/ajmg.1320310422, PMID: 3239579,</ref> It is also known as Cleidorhizomelic syndrome.<ref>Online Mendelian Inheritance in Man (OMIM) Cleidorhizomelic syndrome -119650
</ref>
Presentation[edit]
An initial clinical report of this syndrome describes a 6-month-old boy with rhizomelic shortening, particularly in the arms, and protuberances over the lateral aspects of the clavicles. On radiographs the lateral third of the clavicles had a bifid appearance resulting from an abnormal process or protuberance arising from the fusion center. His 22-year-old mother also had a height of 142 cm with an arm span of 136 cm and rhizomelic shortness of the limbs, maximal in the arms, and abnormalities of the acromioclavicular joints. Both the mother and the son had marked bilateral clinodactyly of the fifth fingers associated with hypoplastic middle phalanx.<ref name=wzg88 />
Cause[edit]
This section is empty. You can help by adding to it. (August 2017) |
Diagnosis[edit]
This section is empty. You can help by adding to it. (August 2017) |
Treatment[edit]
This section is empty. You can help by adding to it. (August 2017) |
References[edit]
External links[edit]
| Congenital malformations and deformations of musculoskeletal system / musculoskeletal abnormality | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| This article is a stub. You can help WikiMD by registering to expand it. |
Wallis–Zieff–Goldblatt syndrome[edit]
-
Diagram showing autosomal dominant inheritance pattern.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
- Articles to be expanded from August 2017
- All articles to be expanded
- Articles with empty sections from August 2017
- Articles with invalid date parameter in template
- All articles with empty sections
- Congenital disorders of musculoskeletal system
- Autosomal dominant disorders
- Genetic disorders with OMIM but no gene
- Rare syndromes
- Syndromes with dysmelia
- Musculoskeletal disease stubs